Moffitt Notice of Blackbaud Data Incident. Learn More
Articles related to Lymphoma
Moffitt’s Top Research Developments of 2017: CAR T Therapy Tested, Commercially Available at Moffitt
The first one on the list of Moffitt's top research developments for 2017 is the FDA approval of CAR T therapy for certain aggressive types of adult lymphoma. Read More
Infographic: How CAR T Therapy Works to Fight Cancer
CAR T therapy, a groundbreaking new treatment, utilizes the body’s own immune system to fight cancer. Read More
What is CAR T Therapy?
Dr. Frederick Locke, vice chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy, answers some frequently asked questions about CAR T cell therapy. Read More
CAR T Cancer Therapy a ‘Huge Breakthrough’ for Patients with Lymphoma
Moffitt patients with an aggressive type of lymphoma were among the first to benefit in clinical trials of a groundbreaking therapy. Read More
September Is Blood Cancer Awareness Month – What You Need to Know
The U.S. Congress has designated September as Blood Cancer Awareness Month. Moffitt Cancer Center is pleased to join in this effort as a way to educate the general public and provide support, strength and hope to individuals who are affected by blood cancer. Read More
September Is Leukemia & Lymphoma Awareness Month
Approximately every four minutes, someone in the United States is diagnosed with leukemia, lymphoma or another type of cancer that affects the blood cells, bone marrow or lymphatic system. Read More
Madison's Story
Madison encourages other young adults with cancer to be fearless. Read More
